Popular Articles

India Eco Summit: Daiichi to launch Ranbaxy's drugs in Japan
Daiichi Sankyo, which has a majority stake in Ranbaxy Laboratories, today said it is going to launch some of Ranbaxy"s generic medicine in the Japanese market soon.

Strides Arcolab launches anti-swine flu drug
Pharmaceutical company Strides Arcolab has launched an anti-swine flu drug.

News of the day

Wipro rises 2%
The Wipro scrip rose two per cent amid falling market to Rs 604.15 after the net profit of the company rose 19 per cent to Rs 1,162 crore in the second quarter of the current financial year, as compared to the same quarter a year ago.
Small Business

NYSE Euronext leads US IPO market with $19 bn proceeds

With more IPO listings on horizon, NYSE Euronext for the fifth consecutive year led the US IPO market, with over $19 billion in proceeds compared with $8 billion on Nasdaq. - Power rules IPO market - 1% of NSE and 6% of MCX on the block - MCX to work on illiquid and agri-contracts in its 7th year - NYSE Euronext Q3 net income plunges 28% to $125 mn - "No point killing the golden goose by hiking realty prices" - 'The nature of the rally is not clear' As of November 30, NYSE Euronext’s European and US markets rank second globally with almost $21 billion raised through IPOs in 2009, just below the near $23 billion in IPO proceeds raised on Hong Kong Exchanges and Clearing (HKEx), the release said. NYSE Euronext US markets have not only raised more in dollar proceeds, but, for the first time, also are scheduled to attract a larger number of IPO transactions than any other US market by year-end. An additional 8 IPOs are scheduled to go public on the NYSE in the next two weeks, to raise an estimated additional $2.7-billion in proceeds, as compared with only one or two more IPOs scheduled on Nasdaq to raise up to an estimated $180 million. "More than any other exchange group, in 2009 NYSE Euronext’s US markets were able to capture the renewed momentum in IPO listings," NYSE Euronext America Head of Listings Scott Cutler said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):